On May 23, 2022 Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), reported it will be presenting at the 2022 ASCO (Free ASCO Whitepaper) Annual Meeting, a conference taking place in Chicago, IL from June 3 to 7, 2022 (Press release, Biomica, MAY 23, 2022, View Source [SID1234614965]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The ASCO (Free ASCO Whitepaper) (American Society of Clinical Oncology) Annual Meeting showcases the most cutting-edge research in clinical oncology and state-of-the-art advanced cancer therapies and is the world’s most influential and prominent scientific gathering of the clinical oncology community. Biomica’s abstract, entitled "A rationally designed live bacterial consortium for the potentiation of immune checkpoint therapy in solid tumors," was selected for a poster and presentation session at the conference.
Furthermore, the poster has also been selected for the 2022 GRASP Advocate Choice Award. GRASP, which stands for Guiding Researchers and Advocates to Scientific Partnerships, and is a patient-led organization that brings together patients, clinicians, and researchers to exchange ideas and learn from each other to accelerate scientific breakthroughs. This is the third year ASCO (Free ASCO Whitepaper) is collaborating with GRASP, and this event will take place in parallel with the conference.
Dr. Corinne Maurice-Dror, Biomica’s Clinical Oncology advisor, will be presenting on Sunday, June 5, 2022 between 8am and 11am CDT.
Furthermore, Dr. Maurice Dror and Dr. Elran Haber, CEO of Biomica will be available for one-on-one meetings at the conference, and those interested should be in touch with the investor or public relations team.